Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan Health System, Ann Arbor, Michigan 48109, USA.
Thyroid. 2010 Jun;20(6):627-31. doi: 10.1089/thy.2009.0320.
It is not known if surgeons who place women of reproductive age on thyroid hormone replacement (levothyroxine, LT4) routinely inform them of the increased LT4 demands with future pregnancy. In addition, it is not clear whether reading the 2007 Endocrine Society's "Guidelines on the Management of Thyroid Dysfunction during Pregnancy and Postpartum" influences the role of the surgeon in patient education. The objective of this study was to identify the role of the surgeon in patient education at the time of initiation of LT4 therapy.
A two-sided one-page survey was distributed to the 260 surgeons attending the 2009 American Association of Endocrine Surgeons' meeting. Of those distributed, 109 (42%) surgeons returned the survey.
Although only 26/109 (23%) read the 2007 Endocrine Society's "Guidelines on the Management of Thyroid Dysfunction during Pregnancy and Postpartum," reading the guidelines was associated with a significantly greater likelihood of informing patients of higher LT4 requirements with pregnancy (p < 0.0001). Eighty-five percent of those who read the guidelines "often" or "always" informed patients of higher LT4 requirements with future pregnancy, whereas only 44% of those who did not read the guidelines provided the same level of education. After controlling for surgeon sex, academic versus private practice, years in practice, and number of surgeries performed in 2008, the only independent predictor of patient education was reading the guidelines (p = 0.006). On multivariable analysis, surgeon volume was associated with reading the guidelines (p = 0.006). The mean number of thyroid surgeries performed by those who read the guidelines versus those who did not was 164.46 +/- 16.98 versus 115.01 +/- 8.27 (p = 0.005).
Surgeons who read the Endocrine Society's "Guidelines on the Management of Thyroid Dysfunction during Pregnancy and Postpartum" were significantly more likely to inform patients of the need for higher LT4 doses with pregnancy. Thyroid surgery volume was associated with guideline awareness.
目前尚不清楚为处于生育年龄的女性开具甲状腺激素替代治疗(左甲状腺素,LT4)的外科医生是否会常规告知其未来妊娠时 LT4 需求增加。此外,不清楚阅读 2007 年内分泌学会的“妊娠和产后甲状腺功能障碍管理指南”是否会影响外科医生在患者教育中的作用。本研究的目的是确定外科医生在开始 LT4 治疗时在患者教育中的作用。
向参加 2009 年美国内分泌外科学会会议的 260 名外科医生分发了一份双面一页的调查问卷。在分发的问卷中,有 109 名(42%)外科医生返回了问卷。
尽管只有 26/109(23%)名外科医生阅读了 2007 年内分泌学会的“妊娠和产后甲状腺功能障碍管理指南”,但阅读该指南与更有可能告知患者妊娠时 LT4 需要量增加(p<0.0001)显著相关。阅读指南的 85%的人“经常”或“总是”告知患者未来妊娠时 LT4 需要量增加,而未阅读指南的人仅 44%提供了相同水平的教育。在控制外科医生性别、学术与私人执业、从业年限以及 2008 年手术数量后,唯一独立的患者教育预测因素是阅读指南(p=0.006)。多变量分析显示,外科医生的手术量与阅读指南相关(p=0.006)。阅读指南的外科医生的平均甲状腺手术量为 164.46±16.98 次,而未阅读指南的外科医生的平均甲状腺手术量为 115.01±8.27 次(p=0.005)。
阅读内分泌学会“妊娠和产后甲状腺功能障碍管理指南”的外科医生更有可能告知患者妊娠时需要更高剂量的 LT4。甲状腺手术量与指南知晓率相关。